Histone lysine demethylases in breast cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Critical reviews in oncology/hematology

• Publication date

  2013-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.critrevonc.2012.11.008PMID 23266085PMCID PMC3622135
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer statistics, 2012

  2012cited by this paper
• Taking a Back Door to Target Myc

  2012cited by this paper
• Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells

  2012influential reference
• Effects of RNA interference-mediated gene silencing of JMJD2A on human breast cancer cell line MDA-MB-231 in vitro

  2011cited by this paper
• GOBO: Gene Expression-Based Outcome for Breast Cancer Online

  2011cited by this paper
• Histone Demethylase JMJD2B Functions as a Co-Factor of Estrogen Receptor in Breast Cancer Proliferation and Mammary Gland Development

  2011cited by this paper
• PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells.

  2011cited by this paper
• Plu-1 / JArId 1 B / Kdm 5 B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in Er + breast cancer cells

  2011cited by this paper
• Targeting Histone Demethylases: A New Avenue for the Fight against Cancer.

  2011cited by this paper
• Enzymatic and structural insights for substrate specificity of a family of jumonji histone lysine demethylases

  2010cited by this paper
• Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology.

  2010cited by this paper
• Structural insights into histone lysine demethylation.

  2010cited by this paper
• Histone demethylase KDM5A is an integral part of the core Notch-RBP-J repressor complex.

  2010cited by this paper
• The canonical Notch signaling pathway: unfolding the activation mechanism.

  2009cited by this paper
• A Novel Mammalian Flavin-dependent Histone Demethylase*

  2009cited by this paper
• The PcG protein hPc2 interacts with the N-terminus of histone demethylase JARID1B and acts as a transcriptional co-repressor.

  2009cited by this paper
• Cancer stem cell epigenetics and chemoresistance.

  2009cited by this paper
• Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease.

  2008cited by this paper
• Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2.

  2008cited by this paper
• A novel variant of the putative demethylase gene, s-JMJD1C, is a coactivator of the AR.

  2007cited by this paper
• UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development

  2007cited by this paper
• Carcinogen-induced histone alteration in normal human mammary epithelial cells.

  2007cited by this paper
• The Function and Regulation of the JARID1 Family of Histone H3 Lysine 4 Demethylases: the Myc Connection

  2007cited by this paper
• Histone demethylation by a family of JmjC domain-containing proteins

  2006cited by this paper
• Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response.

  2005cited by this paper
• Binding of pRB to the PHD protein RBP2 promotes cellular differentiation.

  2005cited by this paper
• ONCOMINE: a cancer microarray database and integrated data-mining platform.

  2004cited by this paper
• A novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31

  2001cited by this paper

• Epigenetic mechanisms and therapeutic advances in breast cancer: From molecular insights to clinical applications.

  2025cites this paper
• 2-oxoglutarate-dependent Dioxygenases (2-OGDDs) as Oxygen Sensors: Their Importance in Health and Disease.

  2024cites this paper
• Update on surveillance guidelines in emerging Wilms tumor predisposition syndromes.

  2024cites this paper
• KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges

  2024cites this paper
• Unraveling the Role of JMJD1B in Genome Stability and the Malignancy of Melanomas

  2024cites this paper
• Epigenetic contribution to the relationship between obesity and cancer.

  2024cites this paper
• Epigenetic roles of KDM3B and KDM3C in tumorigenesis and their therapeutic implications

  2024cites this paper
• The role and prospect of lysine‐specific demethylases in cancer chemoresistance

  2023cites this paper
• Ipsilateral synchronous papillary renal neoplasm with reverse polarity and urothelial carcinoma in a renal transplant recipient: a rare case report with molecular analysis and literature review

  2023cites this paper
• Domain architecture and protein–protein interactions regulate KDM5A recruitment to the chromatin

  2023cites this paper
• Alpha-ketoglutarate-dependent enzymes in breast cancer and therapeutic implications.

  2023cites this paper
• Epigenetics mechanism and therapeutic potential of approved epi-drugs in pulmonary hypertension disease.

  2023cites this paper
• The role of lysine-specific demethylase 6A (KDM6A) in tumorigenesis and its therapeutic potentials in cancer therapy.

  2023cites this paper
• Insights into a Cancer-Target Demethylase: Substrate Prediction through Systematic Specificity Analysis for KDM3A

  2022cites this paper
• Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis

  2022cites this paper
• Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma

  2022cites this paper
• Antioxidant Gene Signature Impacts the Immune Infiltration and Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma

  2021cites this paper
• The emerging role of KDM5A in human cancer

  2021cites this paper
• KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches

  2021cites this paper
• Pharmacological inhibition of KDM5A for cancer treatment.

  2021cites this paper
• KDM3B-ETF1 fusion gene downregulates LMO2 via the WNT/β-catenin signaling pathway, promoting metastasis of invasive ductal carcinoma

  2021influential citation
• Tamoxifen induces stem-like phenotypes and multidrug resistance by altering epigenetic regulators in ERα+ breast cancer cells.

  2020cites this paper
• 2-Oxoglutarate-dependent dioxygenases in cancer

  2020cites this paper
• Expression of the epigenetic H3K27me3 modifier genes KDM6A and EZH2 in patients with upper tract urothelial carcinoma.

  2020cites this paper
• De Novo and Inherited Pathogenic Variants in KDM3B Cause Intellectual Disability, Short Stature, and Facial Dysmorphism.

  2019cites this paper
• Structure-Based Discovery of a Selective KDM5A Inhibitor that Exhibits Anti-Cancer Activity via Inducing Cell Cycle Arrest and Senescence in Breast Cancer Cell Lines

  2019cites this paper
• Lysine demethylases KDM6A and UTY: The X and Y of histone demethylation.

  2019cites this paper
• Weighted correlation network analysis of triple-negative breast cancer progression: Identifying specific modules and hub genes based on the GEO and TCGA database

  2019cites this paper
• Genetic profiling as a clinical tool in advanced parathyroid carcinoma

  2019cites this paper
• Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer

  2019cites this paper
• The Landscape of Histone Modification in Cancer Metastasis

  2018cites this paper
• The impact of the effectiveness of GATA3 as a prognostic factor in breast cancer.

  2018cites this paper
• Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy.

  2018cites this paper
• Profiling plasma extracellular vesicle by pluronic block-copolymer based enrichment method unveils features associated with breast cancer aggression, metastasis and invasion

  2018cites this paper
• Genome-Wide Methylation Analysis Identifies NOX4 and KDM5A as Key Regulators in Inhibiting Breast Cancer Cell Proliferation by Ginsenoside Rg3.

  2018cites this paper
• Targeting epigenome with dietary nutrients in cancer: Current advances and future challenges

  2017cites this paper
• Dysregulation of Apoptosis Caused by Aberrant Histone Modification

  2017cites this paper
• Studies on the Interaction of the Histone Demethylase KDM5B with Tricarboxylic Acid Cycle Intermediates

  2017cites this paper
• Kdm6a and Kdm6b: Altered expression in malignant pleural mesothelioma.

  2017cites this paper
• Novel targets in the treatment of neuroendocrine tumors: RBP2

  2017cites this paper
• The Molecular Basis of Histone Demethylation

  2017cites this paper
• SUMOylated ORC2 Recruits a Histone Demethylase to Regulate Centromeric Histone Modification and Genomic Stability.

  2016cites this paper
• Therapeutic Implications of Epigenetic Signaling in Breast Cancer

  2016influential citation
• Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448

  2016cites this paper
• The cancer COMPASS: navigating the functions of MLL complexes in cancer.

  2015cites this paper
• Knockout of the Histone Demethylase Kdm3b Decreases Spermatogenesis and Impairs Male Sexual Behaviors

  2015cites this paper
• Inhibitors of Jumonji C-Domain Histone Demethylases

  2015cites this paper
• New and under explored epigenetic modulators in search of new paradigms.

  2015cites this paper
• Epigenetic Role of Histone 3 Lysine Methyltransferase and Demethylase in Regulating Apoptosis Predicting the Recurrence of Atypical Meningioma

  2015cites this paper
• The Interaction between Epigenetics, Nutrition and the Development of Cancer

  2015influential citation
• The Histone H3K9 Demethylase Kdm3b Is Required for Somatic Growth and Female Reproductive Function

  2015cites this paper
• Histone demethylase RBP2 is critical for breast cancer progression and metastasis.

  2014cites this paper
• The KDM5 family of histone demethylases as targets in oncology drug discovery.

  2014cites this paper
• Epigenetic pathway targets for the treatment of disease: accelerating progress in the development of pharmacological tools: IUPHAR Review 11

  2014cites this paper
• Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma.

  2014cites this paper
• Molecular mechanisms and physiology of disease

  2014cites this paper
• INTERNATIONAL UNION OF BASIC AND CLINICAL PHARMACOLOGY REVIEW Epigenetic pathway targets for the treatment of disease: accelerating progress in the development of pharmacological tools: IUPHAR Review 11

  2014cites this paper
• Epigenetic Perturbations in the Context of the Multi-hit Hypothesis of Carcinogenesis

  2014cites this paper
• The mutational landscape of chromatin regulatory factors across 4,623 tumor samples

  2013cites this paper